Breast Cancer Hope Foundation is offering $250,000 to support research aimed at identifying cell surface proteins (neoantigens) unique to dormant breast cancer cells. This initiative aims to facilitate the development of effective immunotherapy against these cells, potentially preventing late breast cancer relapse, especially in ER-positive breast cancer cases. President Professor Kefah Mokbel emphasizes the importance of this area, which could lead to breakthroughs in breast cancer treatment. The complex ecosystem of breast cancer, characterized by tumor dormancy and resistance to conventional therapies, underscores the urgent need for innovative approaches to target dormant cells and prevent their reactivation. Join us in our mission to unveil the hidden truths of breast cancer and pave the way for a future free from its shadow.

You can apply by sending a copy of your curriculum vitae and research proposal to the following email address: Kefah.Mokbel@hcahealthcare.co.uk